diabetic%20foot%20infection
DIABETIC FOOT INFECTION

Diabetic foot infection occurs in patients with diabetes as they are prone to microorganism invasion and multiplication in the soft tissue or bone (anywhere below the malleoli) that leads to host inflammatory response that usually results to tissue destruction.

Staphylococci and streptococci are the most common causative organisms although most diabetic foot infections are polymicrobial.

Most infections usually start with a break in the protective cutaneous envelope of the skin that resulted from trauma or neuropathic ulceration.

Management of diabetic foot ulcer in patients with diabetes needs an interdisciplinary approach to address glycemic control, infection, offloading of high-pressure areas, lower extremity vascular status and local wound care.

Drug Information

Indication: Nosocomial & community-acquired pneumonia including concurrent bacteremia, complicated & uncomplicated...

Indication: Adult & ped patients w/ moderate to severe infections caused by susceptible strains of microorganisms, as ...

Indication: Bacterial infections caused by susceptible strains: Community-acquired pneumonia, complicated skin & skin ...

Indication: Short-term treatment of upper & lower resp tract, GUT, skin & soft tissue, bone & joint, & den...

Indication: Short-term treatment for upper & lower resp tract, GUT, skin & soft tissue, bone & joint infection...

Indication: Upper & lower resp tract (including ENT), skin & soft tissue, GUT, bone & joint infections; intra-...

Indication: Serious infections caused by clindamycin-susceptible strains of streptococci, pneumococci & staphylococci ...

Indication: Acute sinusitis & exacerbation of chronic bronchitis. Community-acquired pneumonia. Mild to moderately sev...

Indication: Staph, strep (except Strep faecalis), pneumococci, susceptible Chlamydia trachomatis strains & anaerobic b...

1  /  2
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Infectious Diseases - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Audrey Abella, 06 Aug 2019
The guideline-recommended, single-tablet, fixed-dose regimen comprising bictegravir, emtricitabine, and tenofovir alafenamide (B/F/TAF) was noninferior to the dolutegravir and F/TAF (D/F/TAF) regimen in persons living with HIV (PLHIV), according to data presented at IAS 2019.